SUN PHARMACEUTICAL INDUSTRIES
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
Equity - Authorised | ₹599 Cr | ₹599 Cr | ₹599 Cr | ₹599 Cr | ₹599 Cr |
Equity - Issued | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
Equity Paid Up | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr | ₹240 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹71,978 Cr | ₹63,427 Cr | ₹55,755 Cr | ₹47,771 Cr | ₹46,223 Cr |
Securities Premium | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr | ₹1,187 Cr |
Capital Reserves | ₹368 Cr | ₹368 Cr | ₹368 Cr | ₹368 Cr | ₹368 Cr |
Profit & Loss Account Balance | ₹57,862 Cr | ₹50,155 Cr | ₹43,610 Cr | ₹37,646 Cr | ₹36,598 Cr |
General Reserves | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr | ₹3,562 Cr |
Other Reserves | ₹8,999 Cr | ₹8,155 Cr | ₹7,028 Cr | ₹5,008 Cr | ₹4,507 Cr |
Reserve excluding Revaluation Reserve | ₹71,978 Cr | ₹63,427 Cr | ₹55,755 Cr | ₹47,771 Cr | ₹46,223 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹72,218 Cr | ₹63,667 Cr | ₹55,995 Cr | ₹48,011 Cr | ₹46,463 Cr |
Minority Interest | ₹268 Cr | ₹3,459 Cr | ₹3,320 Cr | ₹3,055 Cr | ₹3,017 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | ₹251 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | ₹251 Cr |
Unsecured Loans | ₹2.52 Cr | ₹1.33 Cr | - | ₹230 Cr | ₹647 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | ₹230 Cr | ₹647 Cr |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹2.52 Cr | ₹1.33 Cr | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-4,215 Cr | ₹-3,932 Cr | ₹-3,487 Cr | ₹-2,818 Cr | ₹-3,512 Cr |
Deferred Tax Assets | ₹6,507 Cr | ₹6,515 Cr | ₹5,695 Cr | ₹4,431 Cr | ₹4,712 Cr |
Deferred Tax Liability | ₹2,292 Cr | ₹2,584 Cr | ₹2,208 Cr | ₹1,613 Cr | ₹1,200 Cr |
Other Long Term Liabilities | ₹752 Cr | ₹802 Cr | ₹1,147 Cr | ₹902 Cr | ₹772 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹474 Cr | ₹414 Cr | ₹343 Cr | ₹369 Cr | ₹327 Cr |
Total Non-Current Liabilities | ₹-2,987 Cr | ₹-2,714 Cr | ₹-1,998 Cr | ₹-1,316 Cr | ₹-1,515 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹6,184 Cr | ₹5,653 Cr | ₹5,682 Cr | ₹4,490 Cr | ₹3,974 Cr |
Sundry Creditors | ₹6,184 Cr | ₹5,653 Cr | ₹5,682 Cr | ₹4,490 Cr | ₹3,974 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹3,254 Cr | ₹2,717 Cr | ₹2,604 Cr | ₹2,927 Cr | ₹4,965 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹25 Cr | ₹43 Cr | ₹41 Cr | ₹29 Cr | ₹47 Cr |
Interest Accrued But Not Due | ₹4.37 Cr | ₹6.94 Cr | ₹22 Cr | ₹2.90 Cr | ₹4.71 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | ₹102 Cr |
Other Liabilities | ₹3,225 Cr | ₹2,667 Cr | ₹2,541 Cr | ₹2,895 Cr | ₹4,812 Cr |
Short Term Borrowings | ₹1,867 Cr | ₹2,844 Cr | ₹5,958 Cr | ₹469 Cr | ₹2,445 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹1,867 Cr | ₹2,844 Cr | ₹5,958 Cr | ₹469 Cr | ₹2,445 Cr |
Short Term Provisions | ₹6,888 Cr | ₹5,769 Cr | ₹5,663 Cr | ₹9,323 Cr | ₹4,762 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹733 Cr | ₹412 Cr | ₹309 Cr | ₹176 Cr | ₹179 Cr |
Provision for post retirement benefits | - | - | - | ₹427 Cr | ₹459 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹6,155 Cr | ₹5,358 Cr | ₹5,354 Cr | ₹8,720 Cr | ₹4,124 Cr |
Total Current Liabilities | ₹18,194 Cr | ₹16,984 Cr | ₹19,906 Cr | ₹17,208 Cr | ₹16,146 Cr |
Total Liabilities | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr | ₹64,110 Cr |
ASSETS | |||||
Gross Block | ₹45,950 Cr | ₹44,320 Cr | ₹43,100 Cr | ₹38,707 Cr | ₹35,579 Cr |
Less: Accumulated Depreciation | ₹23,363 Cr | ₹21,072 Cr | ₹19,035 Cr | ₹16,042 Cr | ₹14,026 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹22,586 Cr | ₹23,248 Cr | ₹24,065 Cr | ₹22,665 Cr | ₹21,553 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹1,234 Cr | ₹1,108 Cr | ₹963 Cr | ₹798 Cr | ₹937 Cr |
Non Current Investments | ₹4,698 Cr | ₹6,441 Cr | ₹5,452 Cr | ₹5,215 Cr | ₹6,482 Cr |
Long Term Investment | ₹4,698 Cr | ₹6,441 Cr | ₹5,452 Cr | ₹5,215 Cr | ₹6,482 Cr |
Quoted | ₹4,149 Cr | ₹5,677 Cr | ₹4,487 Cr | ₹4,243 Cr | ₹5,254 Cr |
Unquoted | ₹956 Cr | ₹879 Cr | ₹1,079 Cr | ₹1,085 Cr | ₹1,341 Cr |
Long Term Loans & Advances | ₹1,016 Cr | ₹2,785 Cr | ₹2,758 Cr | ₹2,881 Cr | ₹4,061 Cr |
Other Non Current Assets | ₹124 Cr | ₹93 Cr | ₹93 Cr | ₹46 Cr | ₹4.67 Cr |
Total Non-Current Assets | ₹35,069 Cr | ₹37,921 Cr | ₹37,341 Cr | ₹32,094 Cr | ₹33,668 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹13,656 Cr | ₹8,585 Cr | ₹9,373 Cr | ₹7,634 Cr | ₹3,130 Cr |
Quoted | ₹2,916 Cr | ₹4,199 Cr | ₹4,935 Cr | ₹4,032 Cr | ₹3,099 Cr |
Unquoted | ₹10,740 Cr | ₹4,386 Cr | ₹4,438 Cr | ₹3,602 Cr | ₹31 Cr |
Inventories | ₹10,243 Cr | ₹9,868 Cr | ₹10,513 Cr | ₹8,925 Cr | ₹8,997 Cr |
Raw Materials | ₹3,436 Cr | ₹3,130 Cr | ₹3,478 Cr | ₹2,914 Cr | ₹3,344 Cr |
Work-in Progress | ₹2,019 Cr | ₹2,010 Cr | ₹2,497 Cr | ₹2,058 Cr | ₹1,829 Cr |
Finished Goods | ₹3,709 Cr | ₹3,735 Cr | ₹3,451 Cr | ₹3,065 Cr | ₹2,976 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹214 Cr | ₹148 Cr | ₹131 Cr | ₹122 Cr | ₹107 Cr |
Other Inventory | ₹864 Cr | ₹846 Cr | ₹955 Cr | ₹767 Cr | ₹741 Cr |
Sundry Debtors | ₹13,046 Cr | ₹11,249 Cr | ₹11,439 Cr | ₹10,485 Cr | ₹9,061 Cr |
Debtors more than Six months | ₹458 Cr | ₹657 Cr | ₹561 Cr | ₹469 Cr | ₹341 Cr |
Debtors Others | ₹12,915 Cr | ₹10,999 Cr | ₹11,293 Cr | ₹10,492 Cr | ₹8,962 Cr |
Cash and Bank | ₹11,332 Cr | ₹10,521 Cr | ₹5,770 Cr | ₹5,033 Cr | ₹6,446 Cr |
Cash in hand | ₹1.59 Cr | ₹1.80 Cr | ₹2.14 Cr | ₹1.52 Cr | ₹1.41 Cr |
Balances at Bank | ₹11,259 Cr | ₹10,496 Cr | ₹5,759 Cr | ₹5,018 Cr | ₹6,415 Cr |
Other cash and bank balances | ₹71 Cr | ₹22 Cr | ₹9.49 Cr | ₹14 Cr | ₹29 Cr |
Other Current Assets | ₹625 Cr | ₹756 Cr | ₹746 Cr | ₹775 Cr | ₹1,319 Cr |
Interest accrued on Investments | ₹62 Cr | ₹43 Cr | ₹33 Cr | ₹10 Cr | ₹6.34 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹375 Cr | ₹414 Cr | ₹372 Cr | ₹286 Cr | ₹279 Cr |
Other current_assets | ₹188 Cr | ₹300 Cr | ₹342 Cr | ₹478 Cr | ₹1,034 Cr |
Short Term Loans and Advances | ₹3,692 Cr | ₹2,454 Cr | ₹2,022 Cr | ₹2,013 Cr | ₹1,489 Cr |
Advances recoverable in cash or in kind | ₹616 Cr | ₹515 Cr | ₹545 Cr | ₹405 Cr | ₹471 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹3,076 Cr | ₹1,939 Cr | ₹1,476 Cr | ₹1,607 Cr | ₹1,018 Cr |
Total Current Assets | ₹52,594 Cr | ₹43,433 Cr | ₹39,862 Cr | ₹34,865 Cr | ₹30,442 Cr |
Net Current Assets (Including Current Investments) | ₹34,400 Cr | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr | ₹14,296 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹87,693 Cr | ₹81,396 Cr | ₹77,225 Cr | ₹66,958 Cr | ₹64,110 Cr |
Contingent Liabilities | ₹4,276 Cr | ₹4,567 Cr | ₹4,061 Cr | ₹3,647 Cr | ₹4,639 Cr |
Total Debt | ₹1,870 Cr | ₹2,846 Cr | ₹6,198 Cr | ₹931 Cr | ₹3,869 Cr |
Book Value | - | 265.36 | 233.38 | 200.11 | 193.65 |
Adjusted Book Value | 301.00 | 265.36 | 233.38 | 200.11 | 193.65 |
Compare Balance Sheet of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹401,282.9 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
MANKIND PHARMA | ₹106,401.0 Cr | 6.8% | 8% | 20.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% |
-0.9% |
4.8% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses